Grifols, S.A. Operating Cycle 2011-2026 | GRFS

Annual Operating Cycle Grifols, S.A.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	0.000171	261	263	275	282	-

All numbers in EUR currency

Maximum	Minimum	Average
282	0.000171	216

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	3.11 K	-	5743.5 %	$ 69.7 M	Canada
Happiness Biotech Group Limited HAPP	1.94 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	32	-	-1.52 %	$ 24.7 M	USA
Compugen Ltd. CGEN	400	$ 2.65	-5.36 %	$ 248 M	Israel
Midatech Pharma plc MTP	245	-	-18.52 %	$ 27.3 M	Britain
Affimed N.V. AFMD	31.4	-	-34.95 %	$ 21.5 M	Germany
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Celyad Oncology SA CYAD	64.4	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	349	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	47.6	-	-	$ 344 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	185	-	-4.36 %	$ 27 M	USA
Coherus BioSciences CHRS	656	$ 1.64	1.86 %	$ 192 M	USA
Anika Therapeutics ANIK	235	$ 14.89	0.07 %	$ 214 M	USA
Advaxis ADXS	3.28 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	115	-	5.93 %	$ 314 M	Canada
Applied Genetic Technologies Corporation AGTC	126	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	40.8	-	-0.23 %	$ 916 M	USA
Arcutis Biotherapeutics ARQT	291	$ 21.11	1.2 %	$ 2.69 B	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA